According to the World Health Organization (WHO), the herpes simplex virus (HSV-1) is primarily transmitted through oral-to-oral contact, which further causes oral herpes and genital herpes. One of the prominent symptoms of HSV-1 is cold sores or herpes simplex labialis (HSL). Herpes infections are highly contagious when symptoms are visible but it can also be transmitted to other people in the absence of symptoms. Thus, the proliferating modes of HSV-1 transmission will augment the need for lip cold sore treatment procedures in China, Hong Kong, Taiwan, South Korea, and other Southeast Asian (SEA) nations.
Browse In-depth Lip Cold Sore Treatment Market Companies’ Strategic Developments
People of China, South Korea, Hong Kong, Taiwan and other SEA countries also use creams and gels for treating cold sores. These products can be purchased from either pharmacies, grocery stores, and e-commerce platforms, or directly . In recent years, the sales of these products were observed to be the highest through pharmacies, due to the surging number of prescriptions. Doctors in these countries usually prescribe anti-cold sore treatment products for HSV-1 infections, which can be procured through pharmacies.
Nowadays, lip cold sore treatment product producing companies, such as Perrigo Company plc, Blistex Inc., Kyungdong Pharmaceutical Co. Ltd., Li & Fung Ltd., Carma Labs Inc., Integria Healthcare (Australia) Pty. Ltd., Church & Dwight Co. Inc., Alliance Pharma plc, and Quantum Health, are actively engaging in mergers and acquisitions to cater to the needs of clinics, hospitals, and individuals residing in SEA nations. For example, in May 2019, Laboratoire HRA Pharma SAS acquired the global distribution rights of the Moderna brand, which consists of treatment products for scar and stretchmarks and skincare products.
According to P&S Intelligence, China dominated the lip cold sore treatment market in China and SEA, and it is expected to consume the treatment products at the highest rate in the forthcoming years. This can be primarily attributed to the soaring prevalence of HSV-1 infection in the rural areas of the country and the mounting public awareness about the disease in the nation. Additionally, the presence of leading treatment product manufacturers in the country is also expected to boost the adoption of such products in the foreseeable future.
Thus, the increasing ways of HSV-1 transmission and surging use of cold sore treatment patches in China and SEA countries will fuel the demand for lip cold sore treatment products in the forthcoming years.
